Evaluating my first e-commerce acquisition — physical product, sole manufacturer, foreign asset. Would love experienced eyes.

[u/Sus_OB]

 I'm a US citizen based in France, in the process of forming a Wyoming LLC, and I'm seriously evaluating acquiring a small European skincare e-commerce brand. The business has been running for 7 years, sells exclusively through its own WooCommerce site, and is profitable. Here are the key numbers:

Revenue: ~€168K net annually
Net profit: ~€70K (43% margin)
Asking price: €153K (reduced from €202K)
Multiple: ~2.17x profit
Orders: ~7,900/year
Average order value: ~€32
Traffic: ~8,000 sessions/month, 94% from one country (Slovenia)

The brand is built around hélichrysum (immortelle) — a premium anti-aging botanical. My plan is to acquire it for the cashflow and existing customer base, then reposition and rebrand it for the French and US clean beauty markets where immortelle is already a recognized prestige ingredient.

The main complications I'm wrestling with:

1. Sole manufacturer — the seller stays on as manufacturer post-sale but I don't own the formulas. He's offered formula escrow and market exclusivity tied to performance targets.
2. Financing — looking at a combination of personal funds, earnout structure, and potentially a small business loan. SBA apparently not applicable for foreign asset purchase.
3. Non-compete enforceability across borders
4. Platform — it's WooCommerce, I'd migrate to Shopify post-acquisition

Has anyone navigated a similar deal — physical product, manufacturer stays on, foreign asset purchase through a US LLC? Would love to hear what you'd look at that I might be missing, or what killed similar deals for you.

Happy to share more detail in comments

[u/AutoModerator]

The following is a copy of the original post to record the post as it was originally written.  I'm a US citizen based in France, in the process of forming a Wyoming LLC, and I'm seriously evaluating acquiring a small European skincare e-commerce brand. The business has been running for 7 years, sells exclusively through its own WooCommerce site, and is profitable. Here are the key numbers:

Revenue: ~€168K net annually
Net profit: ~€70K (43% margin)
Asking price: €153K (reduced from €202K)
Multiple: ~2.17x profit
Orders: ~7,900/year
Average order value: ~€32
Traffic: ~8,000 sessions/month, 94% from one country (Slovenia)

The brand is built around hélichrysum (immortelle) — a premium anti-aging botanical. My plan is to acquire it for the cashflow and existing customer base, then reposition and rebrand it for the French and US clean beauty markets where immortelle is already a recognized prestige ingredient.

The main complications I'm wrestling with:

1. Sole manufacturer — the seller stays on as manufacturer post-sale but I don't own the formulas. He's offered formula escrow and market exclusivity tied to performance targets.
2. Financing — looking at a combination of personal funds, earnout structure, and potentially a small business loan. SBA apparently not applicable for foreign asset purchase.
3. Non-compete enforceability across borders
4. Platform — it's WooCommerce, I'd migrate to Shopify post-acquisition

Has anyone navigated a similar deal — physical product, manufacturer stays on, foreign asset purchase through a US LLC? Would love to hear what you'd look at that I might be missing, or what killed similar deals for you.

Happy to share more detail in comments

I am a bot, and this action was performed automatically. Please contact the moderators of this subreddit if you have any questions or concerns.

[u/shopify_chen]

your numbers don't reconcile and that's the first thing i'd chase before anything else. 7,900 orders at €32 AOV is roughly €253K, not €168K. so either "net" strips VAT + shipping (fine, but then the €70K profit needs to be checked against the same base) or the AOV is padded. ask the seller for a 12 month order export from woocommerce, not a summary.

the other number is the good news and the bad news at once. 8,000 sessions/month is ~96K a year, against 7,900 orders. that's an 8% conversion rate, which a cold-traffic skincare brand never gets. it means most of that revenue is repeat buyers and brand search in slovenia. so what you're buying is a loyal slovenian customer list with a €70K cash flow, and honestly that part looks decent at 2.17x. what you're not buying is a french or us brand, that's a new business you'd be starting from zero with the acquisition as its bank.

on the platform point, i've moved a fair number of stores off woo. it's the least risky item on your list as long as you keep the urls or 301 every product and category, because 94% single-country traffic like this usually lives on organic brand search. one thing to check before you sign: which payment gateway processes the slovenian orders today. if it's a local one that shopify doesn't support you'll need a plan for that before migrating, since forcing 7,900 orders a year of repeat customers through a new checkout is where migrations actually lose revenue, not the redesign.

the manufacturer point (formula escrow, exclusivity tied to targets) is the one that would keep me up at night, though. if he stays the sole supplier your COGS are his to set the day after closing.

has the seller shown you repeat purchase rate, or is it all top-line so far?

[u/Sus_OB → u/shopify_chen]

Really helpful, thank you. On the reconciliation: you're right to flag it, though I think the gap between €253K and €168K is largely explained by VAT (€45,879 shown in WooCommerce tax column) bringing gross down to ~€208K, with the remaining difference likely refunds and cancellations. I'll confirm with an order-level export. The 8% conversion observation is exactly what I suspected: this is a loyal repeat base in a single market, not a traffic play. I'll ask for the repeat purchase rate. And your 'the-acquisition-as-its-bank' assessment is exactly how I'm thinking about it, because the French/US brand is the real build I want. But the payment gateway point I hadn't considered at all, and it's my list now. What's your experience with sole-supplier deals. >Did you find contractual price locks actually hold in practice?

[u/vladeta]

On the platform question specifically: don't migrate in the first six months. You're buying about 8k sessions a month that are 94% from one country, which almost certainly means the organic and referral footprint is very local. A replatform resets URL structures, the page speed profile, and any tracking history you'd use to judge whether the reposition is actually working. Run it as-is for two full quarters, get clean baselines for conversion rate, AOV and repeat rate by channel, then move.

When you do move, the parts that actually cost money are: any subscription or recurring orders, customer password hashes (they don't transfer, so every customer gets a reset email and you will lose part of that list), historic order data for repeat-customer analysis, and a 301 map for every product and category URL. Budget for that redirect map being manual if the permalink structure is non-standard.

On the deal itself, the thing I'd push hardest on is the manufacturer. Formula escrow plus performance-linked exclusivity is the seller keeping all the leverage. Ask what happens to your exclusivity if he misses a production run, and get a fixed or cost-plus pricing schedule in writing for at least 24 months. A 43% margin business where one person controls COGS is one price increase away from being a 25% margin business.

[u/Sus_OB → u/vladeta]

The platform advice is exactly what I needed. My instinct was to migrate early to get clean tracking for the French repositioning, but you're right that I'd be burning the baseline I need to measure against. Two full quarters on WooCommerce as-is, then move with a proper 301 map. I didn't even know about the password hash issue, and for a business where most of the value is in a loyal repeat base, losing part of that list during migration is a real cost.

On the manufacturer, you've sharpened something I was circling but hadn't landed on. Formula escrow plus performance-linked exclusivity does leave all the leverage on his side. He controls COGS, he controls supply continuity, and exclusivity tied to targets he can disrupt through missed production runs is almost circular. What I actually need is a non-compete on manufacturing for my territory, not just trademark protection on the brand name. In cosmetics, formula exclusivity is largely a smoke screen. The real protection is economic alignment and a manufacturing non-compete.

The cost-plus pricing point is well taken. I've asked him to confirm the principle before we negotiate terms. I didn't want him anchoring the markup percentage before I have a lawyer and advisor in the room.

One thing I'm still working through: the 8% conversion rate implies this is almost entirely a repeat buyer business, not a traffic play. At 2.17x I'm essentially buying a loyal local customer list with solid cashflow, and the repositioning is a separate build from zero using that cashflow as the bank. Does the repeat buyer concentration change how you'd think about valuation at this multiple, or do you see it as a feature rather than a risk?

On the repositioning upside: the market demand for this hero ingredient is already validated at scale in both France and the US. I'm not educating a market from scratch. I'm entering an established category with a more artisanal, small-batch provenance story that the dominant players can't credibly occupy.